The Latest Psychedelics Articles from Streetwise Reports

Innovator in Drug Policy Now Listed on the OTCQBA Venture Market

  ()
Safe Supply Streaming Co. Ltd. Announced that it is expanding availability for potential investors. Read on to see why this stock might represent an opportunity as drug policy changes.
Tags:  Psychedelics

Pharma Co. Invests in Clinical Psychedelics

  ()
ATAI Life Sciences N.V. has announced that it is investing in psychedelic treatments for Major Depressive Disorder and Alcohol Use Disorder. Read on to see why one analyst likes this company's stock.
Tags:  Psychedelics

Pharma Co. Gets First US Patent for Repurposed Drug

  ()
Clinical-stage pharmaceuticals firm Algernon Pharmaceuticals Inc. has been issued a U.S. patent for the treatment of three related diseases with its investigational drug repirinast.

Lithium Co. Will Be a Substantial Outperformer

Contributed Opinion
  ()
Michael Ballanger of GGM Advisory Inc. shares a quick note about why he has faith in Volt Lithium Corp.

Drug Reform Streaming Co. Starts Trading on CSE

  ()
This company investing in and incubating companies at the forefront of drug policy reform has started trading on the Canadian Securities Exchange. One writer says buying stock is a chance to be a part of a "movement."

Biotech Co. Makes Strides on Three Fronts

Research Report
  ()
This Canadian firm sold assets, launched an equity raise and filed a clinical trial application for its lead psychedelic-assisted psychotherapy program, noted a Stifel report.
Tags:  Psychedelics

Showing Results: 1 to 6 of 6